PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Donna E. Reece, MD - Cases in Relapsed Refractory Multiple Myeloma: The Role of Anti-CD38–Based Regimens in an Evolving Canadian Landscape
Visit https://www.peervoice.com/PRK860 to view the entire programme with slides. After completing “Donna E. Reece, MD - Cases in Relapsed Refractory Multiple Myeloma: The Role of Anti-CD38–Based Regimens in an Evolving Canadian Landscape”, participants will be able to: Outline the role of anti-CD38–based regimens within the current treatment landscape for relapsed refractory multiple myeloma (RRMM); Discuss the current evidence to inform treatment selection for RRMM for optimal patient outcomes; and Highlight patient and disease factors that may guide treatment sequencing in RRMM.